Clinical trial
A Double-blind, Randomised Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition
NCT00451646 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Randomised Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition
- Lead sponsor
- Fresenius Kabi
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- November 30, 2008
- Enrollment
- 75 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
parenteral nutrition